Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Unicycive Therapeutics (UNCY) Operating Margin (2022 - 2023)

Unicycive Therapeutics filings provide 2 years of Operating Margin readings, the most recent being 622.52% for Q1 2023.

  • On a quarterly basis, Operating Margin changed N/A to 622.52% in Q1 2023 year-over-year; TTM through Dec 2023 was 3077.78%, a N/A change, with the full-year FY2023 number at 3077.63%, down 117942.0% from a year prior.
  • Operating Margin hit 622.52% in Q1 2023 for Unicycive Therapeutics, down from 584.02% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 584.02% in Q3 2022 to a low of 622.52% in Q1 2023.